Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation reports recurring developments across life sciences and diagnostics, including analytical instruments, informatics, service, and high-volume testing workflows. News for WAT commonly covers operating results and guidance, the Analytical Sciences Division, and the Biosciences and Diagnostic Solutions businesses added through the completed BD transaction.
Company updates also include product launches for liquid chromatography, UPLC and UHPLC workflows, MALS detection, rheometry, LC columns, and TA Instruments technologies. Diagnostic news includes FDA-related developments for the Onclarity HPV Self-Collection Kit and BD Onclarity HPV Assay, along with commercial, conference, and shareholder-related updates.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Waters Corporation (NYSE:WAT) will announce its Q1 2023 financial results on May 9, 2023, at 8:00 a.m. Eastern Time. A live webcast will be accessible through the company’s investor relations website, with a replay available until May 23, 2023. Waters Corporation has a rich history of over 60 years in analytical instruments, including chromatography and mass spectrometry, and operates in more than 35 countries with over 8,200 employees globally.
Waters Corporation (NYSE:WAT) has launched the Xevo TQ Absolute IVD System, enhancing its MassTrak IVD portfolio. This state-of-the-art system is the most sensitive benchtop tandem quadrupole mass spectrometer for clinical applications, boasting up to five times the sensitivity of its peers. It features a 45% smaller design and consumes 50% less nitrogen gas and electricity, making it environmentally sustainable. The Xevo TQ Absolute IVD allows laboratories to analyze trace-level analytes in smaller samples, thereby expanding testing capabilities for less-invasive assays. The system aims to improve patient care through advanced diagnostic options.
Waters Corporation (NYSE:WAT) has appointed Richard Fearon to its Board of Directors, effective March 27, 2023. Fearon, former Vice Chairman and Chief Financial Officer of Eaton Corporation, is expected to bring financial expertise and strategic development skills to enhance Waters' growth plan. CEO Udit Batra noted that Fearon's leadership experience will strengthen Waters' competitive position. This change follows the retirement of Edward Conard, who has served on the board since 1994, contributing to an 80-fold stock increase over nearly 30 years. The board will now consist of nine members, with three new appointees over the past year.
Waters Corporation (NYSE:WAT) has launched its Alliance iS High Performance Liquid Chromatography (HPLC) System, designed to enhance quality control in laboratories by reducing common errors by up to 40%. This next-generation system integrates with Empower Chromatography Software and eConnect HPLC Columns, promoting operational risk management and productivity. Featuring an intuitive touchscreen for guided operation and system health monitoring, it helps laboratories meet compliance and product delivery goals. The Alliance iS HPLC System will be available starting May 2023.
Waters Corporation (NYSE: WAT) has launched the Battery Cycler Microcalorimeter Solution, enabling unprecedented battery testing capabilities. This advanced device collects six times more data than competitors and reduces validation time for battery safety and performance by up to 75%. The solution allows simultaneous testing of 12 batteries, enhancing efficiency in battery research. With integrated software, researchers can accurately analyze experiments in real-world conditions, optimizing battery development.
Waters Corporation (NYSE:WAT) has ranked fifth on Barron’s 2023 100 Most Sustainable Companies list, marking its third consecutive year on the list and its second in the top ten. The company emphasizes its commitment to environmental, social, and governance (ESG) goals, including reducing its environmental impact and enhancing workforce diversity. Notable achievements in 2022 included the introduction of the Xevo™ TQ Absolute mass spectrometer, which uses 50% less energy and emits less heat, and the opening of a $215 million Precision Chemistry facility in Taunton, Massachusetts, recognized as LEED-certified.